The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(Azetidin-1-ylmethyl)benzyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide ID: ALA4863719
PubChem CID: 164622165
Max Phase: Preclinical
Molecular Formula: C18H19N5O
Molecular Weight: 321.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccc(CN2CCC2)cc1)c1ccc2nncn2c1
Standard InChI: InChI=1S/C18H19N5O/c24-18(16-6-7-17-21-20-13-23(17)12-16)19-10-14-2-4-15(5-3-14)11-22-8-1-9-22/h2-7,12-13H,1,8-11H2,(H,19,24)
Standard InChI Key: XCHVKCPMWXBIRJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
8.1600 -5.5299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1600 -6.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8732 -6.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5823 -6.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2914 -6.7598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2914 -7.5812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5823 -7.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8732 -7.5812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0728 -7.8317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5529 -7.1684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0728 -6.5052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4509 -6.7598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7418 -6.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0327 -6.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0327 -7.5812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3236 -7.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6104 -7.5812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9013 -7.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1923 -7.5812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6104 -6.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3236 -6.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9785 -6.7953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1881 -7.0078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4006 -7.7981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
3 8 1 0
6 9 2 0
9 10 1 0
10 11 2 0
5 11 1 0
2 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
17 20 1 0
20 21 2 0
14 21 1 0
19 22 1 0
22 23 1 0
23 24 1 0
24 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 321.38Molecular Weight (Monoisotopic): 321.1590AlogP: 1.86#Rotatable Bonds: 5Polar Surface Area: 62.53Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.88CX Basic pKa: 8.36CX LogP: 0.43CX LogD: -0.58Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: -2.29
References 1. Ma XR, Xu L, Xu S, Klein BJ, Wang H, Das S, Li K, Yang KS, Sohail S, Chapman A, Kutateladze TG, Shi X, Liu WR, Wen H.. (2021) Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain., 64 (15.0): [PMID:34279931 ] [10.1021/acs.jmedchem.1c00367 ]